GT-300

N/A

Report date: 2024/12/25 09:15:35
NME

Base Information

Drug NameGT-300
Drug Alias NameGT-300GT300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factors modulators
TargetsTranscription factors
Therapy Area/IndicationsLewy Body Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenerian Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenerian Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLewy Body Disease

Other Information

ATC CodeN/A
Related LinksN/A